These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


77 related items for PubMed ID: 2778713

  • 1. A stereoselective central hypotensive action of atenolol.
    Pearson AA, Gaffney TE, Walle T, Privitera PJ.
    J Pharmacol Exp Ther; 1989 Sep; 250(3):759-63. PubMed ID: 2778713
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I, Lefevre-Borg F, Lhoste F, Sabatier C, Richer C, Giudicelli JF.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [Abstract] [Full Text] [Related]

  • 3. Is the antihypertensive effect of propranolol caused by an action within the central nervous system?
    Smits JF, van Essen H, Struyker-Boudier HA.
    J Pharmacol Exp Ther; 1980 Oct; 215(1):221-5. PubMed ID: 7452486
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats.
    Shen FM, Xie HH, Ling G, Xu LP, Su DF.
    Acta Pharmacol Sin; 2005 Nov; 26(11):1303-8. PubMed ID: 16225751
    [Abstract] [Full Text] [Related]

  • 5. The beta 2 receptor plays a role in the hypotensive effect of L-dopa.
    Quevedo M, Prieto JC, Pérez-Olea J.
    Acta Physiol Pharmacol Ther Latinoam; 1995 Nov; 45(1):19-25. PubMed ID: 8580515
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats.
    Nobre F, da Silva CA, Coelho EB, Salgado HC, Fazan R.
    Am J Hypertens; 2006 Oct; 19(10):1079-83. PubMed ID: 17027832
    [Abstract] [Full Text] [Related]

  • 7. [The effect of some antiarrhythmic drugs on systolic time intervals in normal subjects (author's transl)].
    Breithardt G, Jochum E, Kuhn H, Seipel L.
    Z Kardiol; 1978 Oct; 67(10):6,0-7. PubMed ID: 366939
    [Abstract] [Full Text] [Related]

  • 8. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 9. Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats.
    Shropshire AT, Wendt RL.
    J Pharmacol Exp Ther; 1983 Mar; 224(3):494-500. PubMed ID: 6827474
    [Abstract] [Full Text] [Related]

  • 10. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol.
    Saito K, Furuta Y, Sano H, Yokoyama M, Fukuzaki H.
    Clin Ther; 1994 Mar; 16(2):181-90. PubMed ID: 8062314
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular effects of YM-16151-4: a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent in rats and dogs.
    Uchida W, Shibasaki K, Matsuda Y, Asano M, Takenaka T.
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):247-52. PubMed ID: 7692165
    [Abstract] [Full Text] [Related]

  • 12. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI, Hofferber E, Stenzel W.
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular and respiratory effects of beta-endorphin in anesthetized and conscious rats.
    Sitsen JM, Van Ree JM, De Jong W.
    J Cardiovasc Pharmacol; 1982 Oct; 4(6):883-8. PubMed ID: 6185778
    [Abstract] [Full Text] [Related]

  • 14. Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin).
    Clementi WA, Garvey TQ, Clifton GD, McCoy RA, Brandt S, Schwartz S.
    Chirality; 1994 Oct; 6(3):169-74. PubMed ID: 8024947
    [Abstract] [Full Text] [Related]

  • 15. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ, Hodgson WC, Sutherland SK.
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [Abstract] [Full Text] [Related]

  • 16. Central action of beta-adrenoceptor antagonists on blood pressure after acute administration in rats.
    Davy M, Midol-Monnet M, Heimburger M, Wepierre J, Cohen Y.
    J Pharmacol; 1986 May; 17(1):28-36. PubMed ID: 2872366
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular and pharmacokinetic interactions between nicorandil and adjunctive propranolol, atenolol or diltiazem in conscious dogs.
    Humphrey SJ.
    Methods Find Exp Clin Pharmacol; 1998 Nov; 20(9):779-91. PubMed ID: 10022032
    [Abstract] [Full Text] [Related]

  • 18. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS, Takakura AC, Menani JV, Colombari E.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):164-71. PubMed ID: 17382316
    [Abstract] [Full Text] [Related]

  • 19. [The effects of nicergoline on the heart rate in the normotensive or spontaneously hypertensive rat. Possible participation of central alpha-1 receptors].
    Huchet AM, Schmitt H.
    J Pharmacol; 1986 Jun 01; 17(1):53-9. PubMed ID: 3012204
    [Abstract] [Full Text] [Related]

  • 20. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
    Stoschitzky K, Egginger G, Zernig G, Klein W, Lindner W.
    Chirality; 1993 Jun 01; 5(1):15-9. PubMed ID: 8383518
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.